ARCHIVES

Top Officials Resign From San Antonio’s Institute for Drug Development.

This article is from The Cancer Letter archive.

Vol. 33 No. 03 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

Generic Paclitaxel Approval Withstands Court Challenge.

May 4, 2001

In Brief: NIH Alumni Assn. Formed; Jenney Named Kans. Vice Chancellor; Bloomfield To Move To RPMI

June 9, 1989

Prevention Program Being Developed For Primary Providers

January 29, 1988

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

March 31, 2000

Patient Advocacy: Breast Cancer Coalition Forms PAC To Increase Political Activities

April 18, 1997

New Therapies Could Benefit Patients With Difficult Cancers

June 25, 2010